Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.14279/10537
Title: Living with the Effects of Cutaneous Toxicities Induced by Treatment
Authors: Charalambous, Andreas 
Major Field of Science: Medical and Health Sciences
Field Category: Other Medical Sciences
Keywords: Cutaneous toxicities;Quality of life;Targeted therapies
Issue Date: 9-Jun-2017
Source: Asia-Pacific journal of oncology nursing, 2017, vol. 4, no. 3, pp. 220-223
Volume: 4
Issue: 3
Start page: 220
End page: 223
Journal: Asia-Pacific Journal of Oncology Nursing 
Abstract: The introduction of targeted therapies in cancer treatment was accompanied with promising results including tumor control and patients survival benefits. However, these drugs just like their predecessors were associated with systemic side effects, including frequent and various cutaneous effects. Targeted therapies such as epidermal growth factor receptor, vascular endothelial growth factor receptor, kit, platelet-derived growth factor receptor, and BCR-ABL inhibitors as well as mammalian target of rapamycin inhibitors can induce cutaneous toxicities of varying severity. There are scarce studies on the actual impact of these toxicities on the patients' lives including the physical, social, and psychological aspects and overall quality of life. Patient's perspective in living with and beyond these toxicities remains largely uncharted but essential in optimizing care provided to those receiving treatment with targeted therapies.
URI: https://hdl.handle.net/20.500.14279/10537
ISSN: 23496673
DOI: 10.4103/2347-5625.207729
Rights: © Ann & Joshua Medical Publishing
Type: Article
Affiliation : Cyprus University of Technology 
University of Turku 
Appears in Collections:Άρθρα/Articles

CORE Recommender
Show full item record

Page view(s)

352
Last Week
0
Last month
2
checked on Jun 22, 2024

Google ScholarTM

Check

Altmetric


Items in KTISIS are protected by copyright, with all rights reserved, unless otherwise indicated.